RET-IN-25
Product Specifications
UNSPSC Description
RET-IN-25 (compound 6b) is a RET kinase inhibitor with anticancer activity. RET-IN-25 inhibits medullary thyroid carcinoma (MTC) with IC50s of 3.6 μM (3 days) and 3.0 μM (6 days) against TT(C634R) MTC[1].
Target Antigen
RET
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
cancer
Assay Protocol
https://www.medchemexpress.com/ret-in-25.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=C(SC2=C1C=NC3=CC=C(C=C32)[N+]([O-])=O)C(OCC)=O)C4=CC=C(C)C=C4
Molecular Weight
435.45
References & Citations
[1]La Monica G, et al. Design and Synthesis of Novel Thieno [3, 2-c] quinoline Compounds with Antiproliferative Activity on RET-Dependent Medullary Thyroid Cancer Cells[J]. ACS Omega, 2023.. . .
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-156113/RET-IN-25-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-156113/
Clinical Information
No Development Reported
CAS Number
2965703-02-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E06B0980-01 48 Well
Goat BTB/POZ domain containing adapter for CUL3 mediated RhoA degradation protein 2 (TNFAIP1) ELISA Kit
Ask
View Details E06B0980-02 96 Well
Goat BTB/POZ domain containing adapter for CUL3 mediated RhoA degradation protein 2 (TNFAIP1) ELISA Kit
Ask
View Details